+

WO2002036066A3 - Compositions pharmaceutiques comprenant des complexes de vanadium organiques pour le traitement de l'ischemie - Google Patents

Compositions pharmaceutiques comprenant des complexes de vanadium organiques pour le traitement de l'ischemie Download PDF

Info

Publication number
WO2002036066A3
WO2002036066A3 PCT/IL2001/001004 IL0101004W WO0236066A3 WO 2002036066 A3 WO2002036066 A3 WO 2002036066A3 IL 0101004 W IL0101004 W IL 0101004W WO 0236066 A3 WO0236066 A3 WO 0236066A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
ischemia
pharmaceutical compositions
vanadium
oxovanadium
Prior art date
Application number
PCT/IL2001/001004
Other languages
English (en)
Other versions
WO2002036066A2 (fr
Inventor
Yoram Shechter
Matityahu Fridkin
Itzhak Goldwaser
Original Assignee
Yeda Res & Dev
Yoram Shechter
Matityahu Fridkin
Itzhak Goldwaser
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL13939900A external-priority patent/IL139399A0/xx
Priority claimed from IL14118201A external-priority patent/IL141182A0/xx
Application filed by Yeda Res & Dev, Yoram Shechter, Matityahu Fridkin, Itzhak Goldwaser filed Critical Yeda Res & Dev
Priority to AU2002214222A priority Critical patent/AU2002214222A1/en
Publication of WO2002036066A2 publication Critical patent/WO2002036066A2/fr
Publication of WO2002036066A3 publication Critical patent/WO2002036066A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Des complexes de vanadium organiques peuvent être utilisés dans la prévention et/ou le traitement de l'ischémie cérébrale. Le complexe de vanadium peut être du bis(N-octyl cystéine amide) oxovanadium (IV), bis(maltolato)oxovanadium (IV), bis(picolinato) oxovanadium (IV) ou un complexe de vanadium d'un hydroxamate, de préférence un monohydroxamate, et est de préférence également un complexe de vanadium d'un monohydroxamate de formule R-CO-NHOH.X, où R représente un radical sélectionné parmi: (i) H2N-CH(COY)-(CH2)n-; (ii) H2N-CH(COOH)-CH2-S-CH2-; et (iii) pyridyle, pipéridyle ou tétrahydro-isoquinolinyle, où n représente 1, 2 ou 3, et Y représente OH ou NH2; et X est un composé de vanadium sélectionné parmi un sel de vanadyle (VO2+), de métavanadate (VO¿3?-) ou de vanadate (VO¿4?3-).
PCT/IL2001/001004 2000-11-01 2001-10-30 Compositions pharmaceutiques comprenant des complexes de vanadium organiques pour le traitement de l'ischemie WO2002036066A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002214222A AU2002214222A1 (en) 2000-11-01 2001-10-30 Pharmaceutical compositions comprising organic vanadium complexes for treatment of ischemia

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IL139399 2000-11-01
IL13939900A IL139399A0 (en) 2000-11-01 2000-11-01 Pharmaceutical compositions comprising vanadium complexes of hydroxamates
IL141182 2001-01-30
IL14118201A IL141182A0 (en) 2001-01-30 2001-01-30 Pharmaceutical compositions comprising organic vanadium complexes

Publications (2)

Publication Number Publication Date
WO2002036066A2 WO2002036066A2 (fr) 2002-05-10
WO2002036066A3 true WO2002036066A3 (fr) 2002-08-01

Family

ID=26323987

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2001/001004 WO2002036066A2 (fr) 2000-11-01 2001-10-30 Compositions pharmaceutiques comprenant des complexes de vanadium organiques pour le traitement de l'ischemie

Country Status (2)

Country Link
AU (1) AU2002214222A1 (fr)
WO (1) WO2002036066A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10183934B2 (en) 2015-02-02 2019-01-22 Forma Therapeutics, Inc. Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors
TW201636333A (zh) 2015-02-02 2016-10-16 佛瑪治療公司 作為ｈｄａｃ抑制劑之３－芳基－雙環［４，５，０］異羥肟酸
EP3472131B1 (fr) 2016-06-17 2020-02-19 Forma Therapeutics, Inc. Acides hydroxamiques de 2-spiro-indan-5-yl ou de 2-spiro-indan-6-yl utilisés en tant qu'inhibiteurs de hdac
NL2019605B1 (en) * 2017-09-22 2019-03-28 Cfm Pharma Holding B V Vanadyl and vanadate for use in reducing stress-induced metabolic derangement

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039385A1 (fr) * 1995-06-06 1996-12-12 Pfizer Inc. (indole-2-carbonyl-)-amides substitues en n et leurs derives, servant d'inhibiteurs de la glycogene phosphorylase
WO1999012875A1 (fr) * 1997-09-11 1999-03-18 Yeda Research And Development Co. Ltd. Complexes de vanadium de monohydroxamates et compositions pharmaceutiques les renfermant

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039385A1 (fr) * 1995-06-06 1996-12-12 Pfizer Inc. (indole-2-carbonyl-)-amides substitues en n et leurs derives, servant d'inhibiteurs de la glycogene phosphorylase
WO1999012875A1 (fr) * 1997-09-11 1999-03-18 Yeda Research And Development Co. Ltd. Complexes de vanadium de monohydroxamates et compositions pharmaceutiques les renfermant

Also Published As

Publication number Publication date
AU2002214222A1 (en) 2002-05-15
WO2002036066A2 (fr) 2002-05-10

Similar Documents

Publication Publication Date Title
ATE320806T1 (de) Zink-aminosäure-chelate mit glyzin und einer schwefelhaltigen aminosäure als liganden
DE60225719D1 (de) Cis-2,4,5- triphenyl-imidazoline und ihre verwendung bei der behandlung von tumoren
IL108092A0 (en) Inhibitors of hiv protease useful fot the treatment of aids
DE60228761D1 (de) Pharmazeutische zusammensetzung (kit) enthaltend dihydropyridinonverbindungen und eine verbindung mit immunmodulatorischer (oder antiinflammatorischer) wirkung und ihre verwendung
DE69202396D1 (de) Abbaubare sulfonatgruppenhaltige Chelate, Verwendungen und Zusammensetzungen derselben.
ATE311749T1 (de) Therapeutische verwendung von antimikrobiellen zusammensetzungen, die ein benzoesäureanalog und ein metallsalz enthalten
DK1004578T3 (da) 5-oxo-pyrrolidin-2-carboxylsyrehydroxamidderivater
ATE448199T1 (de) Verbindungen mit taxol-verstärkender wirkung
NZ228893A (en) Substituted quinoline and naphthyridine derivatives and pharmaceutical compositions
MY116716A (en) Discoloration prevention in pyrithione-containing coating compositions
CA2230140A1 (fr) Lutte contre les champignons nocifs au moyen d'une combinaison d'une substance active inhibant la respiration par l'intermediaire du complexe de cytochrome iii, et d'un amide
CA2121523A1 (fr) Derives de sulfonamide
DE69424986D1 (de) Spülmittelzusammensetzungen
WO2002036066A3 (fr) Compositions pharmaceutiques comprenant des complexes de vanadium organiques pour le traitement de l'ischemie
HK1056510A1 (en) Minoxidil-containing preparations
EA199800998A3 (ru) Хелатные соединения металлов с макроциклическими полиаминокарбоновыми соединениями и их использование для диагностических исследований
EP0541802A4 (en) Diphenylmethylpiperazine derivative
WO1998046576A3 (fr) Promedicaments haloalcoxycarbonyles
ATE153664T1 (de) Imidazoacridine und ihre antineoplastische anwendung
WO2004085497A3 (fr) Composition catalytique
BR9812640A (pt) Complexos de monoidroxamatos de vanádio e composições farmacêuticas compreendendo os mesmos
GR3021143T3 (en) Imidazole derivatives and pharmaceutical compositions containing the same.
ATE95978T1 (de) Stabilisierte antimikrobielle mittel, thermoplastische zusammensetzungen, welche sie enthalten und damit hergestellte erzeugnisse.
Dessì et al. EPR investigation of the oxovanadium (IV) complexes formed by the tripeptide glutathione and some related ligands in aqueous solution
EP0696585A4 (fr)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载